Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression

In a pragmatic trial involving older persons with treatment-resistant depression, augmentation of existing antidepressants with aripiprazole was better than augmentation with bupropion or a switch to bupropion.

Saved in:
Bibliographic Details
Published in:The New England journal of medicine Vol. 388; no. 12; pp. 1067 - 1079
Main Authors: Lenze, Eric J., Mulsant, Benoit H., Roose, Steven P., Lavretsky, Helen, Reynolds, Charles F., Blumberger, Daniel M., Brown, Patrick J., Cristancho, Pilar, Flint, Alastair J., Gebara, Marie A., Gettinger, Torie R., Lenard, Emily, Miller, J. Philip, Nicol, Ginger E., Oughli, Hanadi A., Pham, Vy T., Rollman, Bruce L., Yang, Lei, Karp, Jordan F.
Format: Journal Article
Language:English
Published: United States Massachusetts Medical Society 23-03-2023
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In a pragmatic trial involving older persons with treatment-resistant depression, augmentation of existing antidepressants with aripiprazole was better than augmentation with bupropion or a switch to bupropion.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
ISSN:0028-4793
1533-4406
1533-4406
DOI:10.1056/NEJMoa2204462